Breaking News

Middough, Toyo Engineering In Bio-Project Pact

April 19, 2013

Will offer pharma and biopharma engineering solutions in Asia

Middough Inc., a U.S. engineering, architecture, and management services company, has signed an alliance agreement with Toyo Engineering Corp. of Japan to develop and execute biopharmaceutical capital projects in Asia. Middough will combine its pharma and biopharma technical expertise with Toyo’s engineer-procure-construct project delivery capabilities in Asia. Middough will provide technology transfer services to Toyo staff based in Japan and China. The alliance allows both companies to serve global clients requiring pharma and biopharma expertise and engineering solutions in Asia.
 
“We are excited to be leveraging in-country bases of operation to serve this market with our established skills and expertise in biopharmaceuticals,” said Charles K. Dietz, general manager and senior vice president of Middough’s Life Science Business.  “Toyo, Middough and our clients will all gain from this Teaming Agreement by expanding our technical and geographic reach to the rapidly developing biopharmaceutical manufacturing sector in Asia.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks